Shengda Bio-pharm discloses Q1 operating statistics of vitamin products

On 29 April, Zhejiang Shengda Bio-pharm Co., Ltd. (Shengda Bio-pharm) released the quarterly report of Q1 2023 results. Operating revenue for Q1 totalled USD24.51 million (RMB169.28 million), down 8.58% YoY; net profit attributable to equity holders ...

Vitamins China E-News 202305

www.cnchemicals.com